Condensed Consolidated Statements of Stockholder's Equity Statement - USD ($) shares in Thousands, $ in Thousands	Common Stock and Additional Paid in Capital	Treasury Stock	Accumulated Other Comprehensive Income	Accumulated Deficit	Parent	Noncontrolling Interest	Common Stock Shares Outstanding	Total
Balance, beginning of period at Oct. 02, 2021	$ 6,339,506	$ (1,047,202)	$ 40,690	$ (3,480,362)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances under stock plans	1,050
Stock-based compensation expense	9,032
Sale of noncontrolling interest	0
Repurchases of treasury stock		$ (68,823)
Other comprehensive income			2,696
Net income attributable to common shareholders					$ 56,177			$ 56,177
Noncontrolling Interest in Joint Ventures at Oct. 02, 2021						$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of noncontrolling interest						0
Net income attributable to noncontrolling interest						0		0
Noncontrolling Interest in Joint Ventures at Jan. 01, 2022						0
Number of shares, beginning of period at Oct. 02, 2021							108,734
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances under stock plans							784
Number of shares, end of period at Jan. 01, 2022							109,518
Number of shares, beginning of period at Oct. 02, 2021		(44,427)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of treasury stock		(1,771)
Number of shares, end of period at Jan. 01, 2022		(46,198)
Balance, end of period at Jan. 01, 2022	6,349,588	$ (1,116,025)	43,386	(3,424,185)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total stockholders' equity								1,852,764
Total stockholders' equity								1,819,536
Balance, beginning of period at Oct. 01, 2022	6,381,348	(1,378,159)	56,325	(3,239,978)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances under stock plans	173
Stock-based compensation expense	11,609
Sale of noncontrolling interest	78,169
Repurchases of treasury stock		$ (8,009)
Other comprehensive income			6,950
Net income attributable to common shareholders					$ 92,014			92,014
Noncontrolling Interest in Joint Ventures at Oct. 01, 2022						0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of noncontrolling interest						132,132
Net income attributable to noncontrolling interest						3,100		3,100
Noncontrolling Interest in Joint Ventures at Dec. 31, 2022						$ 135,232
Number of shares, beginning of period at Oct. 01, 2022							110,160
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances under stock plans							342
Number of shares, end of period at Dec. 31, 2022							110,502
Number of shares, beginning of period at Oct. 01, 2022		(52,766)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of treasury stock		(136)
Number of shares, end of period at Dec. 31, 2022		(52,902)
Balance, end of period at Dec. 31, 2022	$ 6,471,299	$ (1,386,168)	$ 63,275	$ (3,147,964)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total stockholders' equity								$ 2,135,674